- Cencora, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor with over $321 billion in revenue for 2025, specializing in a wide range of healthcare products including branded and generic drugs.
- In the past year, Cencora has completed the acquisition of OneOncology and announced a $1 billion investment to expand its U.S. distribution network, including a new national distribution center in Harrison, Ohio, and expansions in California and Alabama.
- The company serves a diverse customer base, including healthcare providers and pharmacies, and is focused on enhancing the resilience and efficiency of the pharmaceutical supply chain to ensure timely access to medications.
- Cencora's ideal buyers are healthcare providers looking for reliable and efficient pharmaceutical distribution solutions, particularly as the company strengthens its infrastructure to meet evolving market demands.
Cencora's workforce is organized across 18 departments, with a notable concentration in Operations, which employs 1,133 individuals. Information Technology follows with a headcount of 540, reflecting the company's commitment to technological infrastructure. Sales and Community and Social Services also contribute significantly to the workforce, with 341 and 333 employees, respectively. This diverse departmental mix underscores a balanced approach to operational efficiency and service delivery.
Cencora operates from 457 locations, with the largest concentration in Wayne, PA, housing 594 employees, followed by Conshohocken, PA, with 251. Frisco, TX, also plays a significant role with 212 employees. The 'Other' category, comprising 2,091 employees, indicates a distributed workforce across various regions, suggesting a strategic geographic presence that enhances operational reach while maintaining a strong local footprint in key areas.
